OrthoPediatrics this week said it launched its Large Fragment Cannulated Screw System in the U.S. The screw system is designed to address trauma procedures and treat children with Slipped Capital Femoral Epiphysis. The system features screws in 2mm increments, screw thread run out in the head of the screw, dual lead threads and threaded cannulation. […]
Keystone Heart cerebral embolic protection device wins CE Mark
Keystone Heart this week said it won CE mark approval for its TriGuard 3 Cerebral Embolic Protection device. TriGuard 3 is designed to reduce the risk of cerebral damage by deflecting debris from cerebral circulation during trans catheter aortic valve implantation and other transcatheter heart procedures, according to the company. “Even with increased operator experience […]
Invacare sells Dynamic Controls business to Allied Motion
Invacare (NYSE:IVC) today said it sold its Dynamic Controls subsidiary to Allied Motion Technologies for an undisclosed amount. The transaction was completed on March 7. As part of the deal, Invacare entered a long-term product supply agreement with Dynamic Controls, which includes ongoing supply and support of the Linx system. The agreement also said that Invacare […]
Neuronetics president and CEO stepping down
Neuronetics (NSDQ:STIM) recently announced that president and CEO Christopher Thatcher would be stepping down, effective immediately. Thatcher also resigned as director of the board of directors and his employment is expected through May 1. He will continue to provide transition services and advice to the company. Neuronetics said that Thatcher’s resignation was a mutual agreement and […]
Alphatec posts wider-than-forecast losses in Q4 results
Alphatec (NSDQ:ATEC) this week posted fourth-quarter results that beat the revenue consensus forecast on Wall Street but missed on earnings. The Carlsbad, Calif.-based company reported losses of $17 million, or -28¢ per share, on sales of $32.4 million for the three months ended Dec. 31, 2019, for a bottom-line sales loss of -71.4% compared with Q4 […]
CryoLife wins CE mark for E-vita Open NEO stent graft system
CryoLife Inc. (NYSE:CRY) this week said it won CE mark approval for the E-vita Open NEO hybrid stent graft system to treat aortic arch disease. The hybrid stent graft technologies allow for a one-stage procedure treatment of this condition by combining the surgical arch repair and endovascular descending thoracic repair. “We are pleased to have received […]
Mauna Kea lands 510(k), CE Mark for next-gen Cellvizio platform
Mauna Kea (ENT:MKEA) this week said it won FDA clearance and CE Mark approval for its next-generation Cellvizio endomicroscopy platform. The Cellvizio uses modular design solutions to better integrate endomicroscopy in procedure suites and third-party platforms. The new platform was designed to facilitate future developments that include deep learning capabilities for assisted image interpretation. It’s also […]
Owens & Minor shares down 20% on mixed Q4 results
Owens & Minor (NYSE:OMI) posted fourth-quarter results today that beat the earnings consensus on Wall Street but missed on earnings. The Mechanicsville, Va.-based company reported losses of -$39 million, or -65¢ per share, on sales of $2.2 million for the three months ended Dec. 31, 2019, for a bottom-line sales loss of -10% compared with Q4 […]
Neuronetics stocks up on Street-beating Q4 results
Neuronetics (NSDQ:STIM) this week posted fourth-quarter results that beat the consensus forecast on Wall Street. The Malvern, Penn.-based company reported profits of $3 million, or -41¢ per share, on sales of $17.4 million for the three months ended Dec. 31, 2019, for a bottom-line sales growth of 11% compared with Q4 2018. Earnings per share were […]
Access Vascular wins FDA clearance for HydroPICC catheter
Access Vascular this week received FDA clearance for its second-generation HydroPICC peripherally inserted central catheter. The HydroPICC has demonstrated thrombus accumulation rate 30 times less than traditional peripherally inserted central catheters (PICC), according to the company. PICCs can help reduce the risk of catheter occlusions have become a popular choice over traditional central venous lines […]
Livongo beats The Street in Q4 results
Livongo Health (NSDQ:LVGO) this week posted fourth-quarter results that beat the consensus forecast on Wall Street. The Mountain View, Calif.-based company reported losses of -$6 million, or -6¢ per share, on sales of $50.4 million for the three months ended Dec. 31, 2019, for a bottom-line sales growth of 137.5% compared with Q4 2018. Adjusted to […]